vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Safehold Inc. (SAFE). Click either name above to swap in a different company.
Safehold Inc. is the larger business by last-quarter revenue ($97.9M vs $77.6M, roughly 1.3× Bioceres Crop Solutions Corp.). Safehold Inc. runs the higher net margin — 28.5% vs -9.6%, a 38.1% gap on every dollar of revenue. On growth, Safehold Inc. posted the faster year-over-year revenue change (6.5% vs -16.8%). Over the past eight quarters, Safehold Inc.'s revenue compounded faster (2.5% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.
BIOX vs SAFE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $97.9M |
| Net Profit | $-7.4M | $27.9M |
| Gross Margin | 46.8% | 98.6% |
| Operating Margin | 9.3% | 27.4% |
| Net Margin | -9.6% | 28.5% |
| Revenue YoY | -16.8% | 6.5% |
| Net Profit YoY | -20.2% | 7.1% |
| EPS (diluted) | $-0.12 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $97.9M | ||
| Q3 25 | $77.6M | $96.2M | ||
| Q2 25 | — | $93.8M | ||
| Q1 25 | $60.6M | $97.7M | ||
| Q4 24 | $98.8M | $91.9M | ||
| Q3 24 | $93.3M | $90.7M | ||
| Q2 24 | — | $89.9M | ||
| Q1 24 | $84.0M | $93.2M |
| Q4 25 | — | $27.9M | ||
| Q3 25 | $-7.4M | $29.3M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | $-1.6M | $29.4M | ||
| Q4 24 | $605.2K | $26.0M | ||
| Q3 24 | $-6.2M | $19.3M | ||
| Q2 24 | — | $29.7M | ||
| Q1 24 | $9.8M | $30.7M |
| Q4 25 | — | 98.6% | ||
| Q3 25 | 46.8% | 98.5% | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | 39.4% | 98.8% | ||
| Q4 24 | 42.0% | 98.8% | ||
| Q3 24 | 40.2% | 98.8% | ||
| Q2 24 | — | 98.8% | ||
| Q1 24 | 50.8% | 98.8% |
| Q4 25 | — | 27.4% | ||
| Q3 25 | 9.3% | 25.9% | ||
| Q2 25 | — | 25.5% | ||
| Q1 25 | 1.5% | 25.9% | ||
| Q4 24 | 14.5% | 24.6% | ||
| Q3 24 | 2.5% | 17.5% | ||
| Q2 24 | — | 26.7% | ||
| Q1 24 | 15.7% | 26.4% |
| Q4 25 | — | 28.5% | ||
| Q3 25 | -9.6% | 30.5% | ||
| Q2 25 | — | 29.8% | ||
| Q1 25 | -2.6% | 30.1% | ||
| Q4 24 | 0.6% | 28.3% | ||
| Q3 24 | -6.6% | 21.3% | ||
| Q2 24 | — | 33.0% | ||
| Q1 24 | 11.6% | 33.0% |
| Q4 25 | — | $0.38 | ||
| Q3 25 | $-0.12 | $0.41 | ||
| Q2 25 | — | $0.39 | ||
| Q1 25 | $-0.02 | $0.41 | ||
| Q4 24 | $0.00 | $0.36 | ||
| Q3 24 | $-0.10 | $0.27 | ||
| Q2 24 | — | $0.42 | ||
| Q1 24 | $0.14 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $21.7M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $288.3M | $2.4B |
| Total Assets | $734.9M | $7.2B |
| Debt / EquityLower = less leverage | — | 1.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.7M | ||
| Q3 25 | $15.5M | $12.1M | ||
| Q2 25 | — | $13.9M | ||
| Q1 25 | $38.5M | $17.3M | ||
| Q4 24 | $29.2M | $8.3M | ||
| Q3 24 | $32.3M | $15.6M | ||
| Q2 24 | — | $13.4M | ||
| Q1 24 | $16.4M | $11.3M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | — | $4.1B |
| Q4 25 | — | $2.4B | ||
| Q3 25 | $288.3M | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | $345.0M | $2.4B | ||
| Q4 24 | $346.3M | $2.3B | ||
| Q3 24 | $346.0M | $2.3B | ||
| Q2 24 | — | $2.3B | ||
| Q1 24 | $348.5M | $2.3B |
| Q4 25 | — | $7.2B | ||
| Q3 25 | $734.9M | $7.1B | ||
| Q2 25 | — | $7.1B | ||
| Q1 25 | $798.2M | $6.9B | ||
| Q4 24 | $835.2M | $6.9B | ||
| Q3 24 | $827.3M | $6.8B | ||
| Q2 24 | — | $6.8B | ||
| Q1 24 | $836.1M | $6.7B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.89× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $47.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $47.8M | ||
| Q3 25 | $14.4M | $-1.4M | ||
| Q2 25 | — | $28.0M | ||
| Q1 25 | $23.3M | $8.9M | ||
| Q4 24 | $-5.4M | $37.9M | ||
| Q3 24 | $5.2M | $8.3M | ||
| Q2 24 | — | $24.8M | ||
| Q1 24 | $-17.4M | $-3.1M |
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | -0.05× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | -8.85× | 1.45× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | -1.78× | -0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
SAFE
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $60.3M | 62% |
| Other | $33.7M | 34% |
| Stabilized Properties | $3.8M | 4% |
